Visit the Alzheimer's Association Research Center - alz.org/research
Participating in Research - Alzheimer's Association Trial Match
If you are interested in participating in research, you can find local and regional research studies that are currently recruiting using the Alzheimer's Association Trial Match program. You can search on-line or simply call 1.800.272.3900. Click here to learn more.
Find Alzheimer’s Disease and Related Clinical TrialsSearch for clinical trials and studies in your area related to Alzheimer's, other dementias, mild cognitive impairment, and caregiving.
Local Clinical Trial
Dr. Lawrence Goldstick
Description: Several drug studies of Alzheimer's Disease / Dementia / Age Association Memory Impairment. Study drugs include LY3202626, Crenezumab and Solanezumab. Please contact the research coordinator listed below to learn more and discuss your situation.
Kayla Stallworth, CRC
Clinical Research Coordinator
UC Health Neurology (affiliated with UC but located in Dayton)
1 Elizabeth Place, Suite 210
Dayton, OH 45417
Local Clinical Trial
Research studies at Valley Medical Research, Meenakski Patel, MD, Principal Investigator
Description: Several drug studies for people with mild to moderate cognitive impairment or Alzheimer's. In addition, one study of agitation and Alzheimer's and another for a brain donation study for those with <6 mos. life expectancy. For more information, please contact the research coordinator listed below:
All studies require a caregiver or study partner, all studies have a placebo, all studies compensate for time and travel.
Cynthia Whittington, RN, MSN
Valley Medical Research
Meenakshi Patel, MD (PI)
6611 Clyo Road
Local Clinical TrialEarly Alzheimer's Disease Clinical Research Study
Description: The EXPEDITION-PRO study will test whether the intravenous investigational drug, solanezumab, slows the worsening of Alzheimer's disease (AD) as compared to placebo in people with early Alzheimer's disease. About the study The EXPEDITION-PRO Study is a clinical research study involving men and women who have early AD. It is being conducted worldwide to find out if the study drug is safe and effective in slowing down the progression of the disease. Approximately 2,450 participants are expected to join this study worldwide.
Grace R. Smither
Tel: 937.224.8200 Ext 125
Dr. Joel Vandersluis, MD
Neurology Diagnostics, Inc.
240 West Elmwood Dr., Ste 1000
Dayton, OH 45459